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\s=b\A review of the records for evidence
of dementia using criteria adapted from
the third edition of the Diagnostic and
Statistical Manual of Mental Disorders in
every patient (hospitalized and outpa-
tient) with parkinsonism at a major medi-
cal center during an 18-month period
revealed an overall prevalence of 10.9%
in 339 patients with idiopathic Parkin-
son's disease. Demented patients were
older, had a later age at onset of motor
manifestations, and a more rapid progres-
sion of physical disability than nonde-
mented patients. Duration of illness and
levodopa use and the presence of tremor
or depression were similar in demented
and nondemented patients. Demented
patients more often responded poorly or
developed adverse effects to levodopa
than nondemented patients. When Parkin-
son's disease began after age 70 years,
dementia was noted over three times
more frequently than when the disease
began at an earlier age. The age-specific
prevalence rate of dementia for patients
older than 70 years was more than twice
that for younger patients. Moreover, the
number of records with evidence for
dementia with idiopathic Parkinson's dis-
ease was 3.75 times greater than ex-
pected in comparison with data from a
study of the prevalence of dementia in the
elderly.
{Arch Neurol 1988;45:260-262)
T^he prevalence of dementia in Par¬
kinson's disease (PD) is unsettled;
estimates range from 14% to 40%.'
Brown and Marsden2 reviewed 17
studies reported over the last 60 years
that included a total of 2530 patients
with PD. Thirty-five percent of these
patients had some degree of dementia,
but the prevalence of dementia could
have been overestimated because of
sampling variability and differences
in criteria used for the diagnosis of
dementia or idiopathic PD.
To estimate the frequency of
dementia in PD, we reviewed the
records of over 422 patients with par-
kinsonism from an urban hospital
population, using standardized re¬
search criteria for dementia and idio¬
pathic PD. Of the records with suffi¬
cient evidence to warrant a diagnosis
of dementia, 10.9% of the 339 patients
with idiopathic PD were demented.
Compared with a data set from a
standard population of elderly adults
older than 60 years, the odds of devel¬
oping dementia appear to be almost
four times greater for patients with
idiopathic PD.3
SUBJECTS AND METHODS
We reviewed the records of every patient(hospitalized or outpatient) with parkin-
sonism in a major teaching hospital seen
on all services during the 18 months
between March 1, 1983, and Sept 30, 1984.
The population included both private and
clinic patients. Although the hospital is a
tertiary care institution, 90% of the
patients came from the greater New York
area and were followed up annually. The
population was representative of a large
urban hospital-based cohort. When a
patient had more than one visit (hospital
and/or outpatient visits) during the study
period, only the first encounter was used in
estimating the prevalence of dementia. All
available information, including that from
subsequent chart entries, was used to sub¬
stantiate a diagnosis regardless of when it
was recorded, however.
Data Extraction
A systematic data collection form to
extract clinical information from records
was designed by us before the survey.
Consensus on criteria for the diagnoses to
be described below was reached before the
study, and the data form was used in a
brief pilot survey before the formal data
extraction began.
Diagnoses
Criteria for the diagnosis of idiopathic
PD included the presence of at least two of
the four characteristic motor manifesta¬
tions of the disorder (tremor, shuffling
gait, bradykinesia, or muscular rigidity)
with a history of insidious onset. Patients
with parkinsonism, resulting from enceph¬
alitis, medications, or multiple stroke,
were eliminated from further consider¬
ation, as were patients with progressive
supranuclear palsy.
We based our research diagnostic crite¬
ria for primary degenerative dementia and
major depression on the definitions in the
third edition of the Diagnostic and Statisti¬
cal Manual of Mental Disorders (DSM-
III)." Briefly, we defined dementia as a
sustained impairment in intellectual func¬
tion, including memory, that was not con¬
sidered drug related and occurred without
an alteration in consciousness. This was
done by reviewing subsequent chart
entries to note whether the mental impair¬
ment, if present, was sustained or tran¬
sient. We required a written description of
a mental status examination by a neurolo¬
gist or psychiatrist in the record that
included an assessment of memory, orien¬
tation, and general knowledge. For demen¬
tia, all mental functions listed above had to
be defective; disorientation alone was con¬
sidered insufficient criteria for this diag¬
nosis. In some patients quantitative, neu-
ropsychological data were present, allow¬
ing a more precise diagnosis. The diagnosis
of dementia or idiopathic PD was retracted
only if it was later refuted, in the record,
by a qualified physician, such as a neurolo¬
gist or psychiatrist. This is similar to the
method used by Rajput et al.5 We defined
depression as a dysphoric mood character¬
ized by feelings of sadness and associated
with changes in appetite and sleep hab¬
its.
We also recorded other features of PD:
age at onset (defined as the time that the
diagnosis of PD was first made by a quali¬
fied physician) and duration of PD motor
manifestations (defined as the period from
the onset of the illness to the first encoun¬
ter recorded during the study period). In
almost half oí the patients, disease severi¬
ty, including the presence or absence of
dementia or depression, had been rated on
the Columbia University PD rating scale.6
Ability to perform activities of daily living(AUL) was also usually rated.7 The disease
was classified as tremulous or nontremu-
lous type, depending on the presence or
absence of a resting tremor. Response to
levodopa therapy was ascertained: patients
were classified as responders (good
response to average dosages), secondary
nonresponders (ie, good response at first
but later not adequate despite sufficient
Accepted for publication Oct 13, 1987.
From the Departments of Neurology (Drs
Mayeux, Stern, Marder, Hauser, Cote, and Fahn
and Ms Rosenstein), Psychiatry (Drs Mayeux and
Stern), and Rehabilitation Medicine (Dr Cote),
College of Physicians and Surgeons, Columbia
University, New York.
Reprint requests to Neurological Institute, 710
W 168th St, New York, NY 10032 (Dr Mayeux).
Downloaded From: http://archneur.jamanetwork.com/pdfaccess.ashx?url=/data/journals/neur/16140/ by a Columbia University User  on 06/13/2017
dosage), or primary nonresponders (never
had a good response). Duration of symp¬
toms before and after levodopa therapy
was started, as well as current total daily
dose, was noted.
We estimated the rate of progression of
PD by dividing patients into three groups
at the time of chart review: benign (ADL
score >70% after five years of illness),,
average (ADL, 50% to 70% after three
years), and rapid (ADL <50% within one
year of illness). Since some patients were
hospitalized, we systematically recorded
the reason for hospitalization because of
its potential influence on our data.
Almost half of the data extraction forms
were completed by clinicans at or near the
time of an office visit. The other half,
which included all of the hospitalized
patients, were completed after chart
review by two other clinicians (R.R. and
R.M.). We compared the results of the data
retrospectively with those collected at the
office visit. In addition, three of us inde¬
pendently rereviewed 59 selected records.
This second review consisted of randomly
selected records from the demented
patients matched to nondemented pa¬
tients. Interrater agreement about the
presence or absence of depression and
dementia and a comparison with the previ¬
ously recorded diagnoses were assessed by
a /f-statistic8 that is chance corrected.
Comparison Group
Because we wanted to estimate the fre¬
quency of dementia expected at this age,
we used prevalence data from the Balti¬
more Longitudinal Study (BLS)3 for com¬
parison. That study included volunteers
older than the age of 60 years. By multiply¬
ing the number of patients with PD in each
age group by the age-specific prevalence
rate observed in the BLS we could estimate
the number of cases of dementia that
might have been expected in people older
than the age of 70 years.
RESULTS
The records of 422 patients with
parkinsonism were reviewed; of these,
355 were judged to have idiopathic
PD. Sixteen of the patients with idio¬
pathic PD had the onset of motor
symptoms before the age of 40 years
and were excluded from further anal¬
ysis because of the unusual age of
onset. This left 339 patients in the
study: 264 (78% ) were outpatients and
75 (22% ) were hospitalized during the
study period. A mental status exami¬
nation was not recorded in three
patients, but their data were still
included in the study without a diag¬
nosis regarding dementia to maintain
a conservative prevalence estimate.
Of the 75 hospitalized patients, 50
were admitted for various problems
related to PD, such as medication
adjustments or drug trials. Another
25 were hospitalized for medical or
surgical problems unrelated to PD,
Prevalence of Dementia in Parkinson's Disease (PD) Compared With
Baltimore Longitudinal Study Sample3
Group Observed Expected SMR* 95% CI (SMR)t
All patients with PD
older than 60 y 9.38 3.84 (2.69, 5.19)
PD onset before 70 y (3.04, 6.95)
PD onset after 70 y 13 2.73 (1.45, 4.43)
* SMR indicates standardized morbidity ratio.
t95% CI (SMR) indicates 95% confidence Interval for the SMR.
such as myocardial infarction or
pneumonia.
We found sufficient evidence for
dementia in the records of 37 (10.9%)
of the 339 study patients with PD seen
during the prevalence period. Demen¬
tia was recorded in the charts of 18(24% ) of 75 hospitalized patients and
19 (7%) of 264 outpatients (z = 3.95,
 < .001). Demented patients were
significantly older (74.03 ± 8.17 years
vs 66.91 ± 8.92 years;  < .01), had a
later age at onset of the motor mani¬
festations of PD (65.28 ± 10.43 years
vs 59.25 ± 9.67 years;  < .01), had
more severe manifestations (mea¬
sured by the Columbia University PD
rating scale6: 50.32 ± 19.27 vs 31.46 ±
18.12,  < .01), and were significantly
more disabled than the patients with¬
out dementia (measured by the
Schwab and England7 ADL scale:
44.0% ± 21.97% vs 74.55% ± 20.39%,
 < .01). The proportion of demented
patients whose motor manifestations
began after the age of 70 years was
significantly greater than the propor¬
tion of demented patients whose
motor manifestations began at an
earlier age (<69 years, 23 [8.5%] of
272; >70 years, 14 [20.9%] of 67:
2 = 2.933, P<.001). Demented pa¬
tients more often had a rapid progres¬
sion of disability than nondemented
patients ( 2 4.48,  < .05). Duration of
illness, levodopa use and mean dosage,
type of PD (tremulous vs nontremu-
lous), and prevalence of depression(47% in the total sample) were similar
in demented and nondemented pa¬
tients. However, the frequency of
demented patients classified as either
primary or secondary nonresponders
to dopaminergic medications and the
number developing adverse effects at
relatively low doses was significantly
greater than in the nondemented
group ( 2 9.41,  < .01). Onset of PD(motor manifestations) after age 70
years occurred more often in the
demented than in the nondemented
patients ( 211.41,  < .01); the preva¬
lence odds ratio for dementia in
patients with onset of PD after the
age of 70 years compared with those
with onset before the age of 70 years
was 3.75 (95% confidence interval,
1.75, 7.95).
Thirty-seven patients had taken the
Modified Mini-Mental State Exami¬
nation at the time of their entry into
the prevalence survey. Although the
number of patients tested was small,
the results agreed with the chart
reviews. There were 33 nondemented
patients (mean score, 51.0) and four
demented patients (mean score, 24.5)(t = 4.33,  < .02). The total score for
the Modified Mini-Mental State
Examination is 57, and mean for
elderly control subjects is 52.3 ± 17.
No differences were apparent in the
prevalence of dementia, age of onset,
or duration of illness when the infor¬
mation was collected near the time of
an office visit or extracted at a later
date from the record. Interrater
agreement for the diagnosis of demen¬
tia from the medical records was 91 %
between the three independent re¬
viewers. After correcting for chance
agreement, the  -statistic8 indicated
that the agreement between the
reviewers was 88%. The agreement
between these reviewers and the orig¬
inally collected data was also high:
87%.
To compare the prevalence of
dementia in our study with a standard
population we used the data from the
BLS.3 We compared the prevalence of
dementia in the 272 patients older
than 60 years with idiopathic PD from
our study with that data set; dementia
was found 3.84 times more often than
expected for that age group (Table).
When PD began before the age of 70
years, dementia was noted in the
records 4.8 times more often than
would have been expected based on
the BLS data, but when PD began
after the age of 70 years, dementia
was recorded 2.73 times more often
than expected.
COMMENT
Using standardized criteria for
dementia and for idiopathic PD, we
found evidence of dementia in the
records of 10.9% of patients with PD.
While this may support the claim that
the overall prevalence of dementia in
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PD has been overestimated,2·'·10 it
must be realized that we also found
age-specific prevalence rates to
increase after age 60 years. The retro¬
spective and cross-sectional nature of
the chart review makes it likely that
we identified only severe dementia
and underestimated the prevalence of
mild dementia. We also may have
slightly underestimated dementia by
determining rates based on the first
encounter during the prevalence peri¬
od. However, our results do indicate
that dementia in patients with PD is
almost four times more frequent than
expected in people older than the age
of 60 years.
Although the prevalence of demen¬
tia in the general population increases
with advanced age, the standardized
morbidity ratios indicate that the
prevalence of dementia in this cohort
with idiopathic PD is almost five
times that expected for healthy people
younger than the age of 70 years and
almost three times greater than
expected for healthy people older than
70 years. The reduction in the stan¬
dardized morbidity ratio after the age
of 70 years probably reflects the
increased prevalence of dementia in
the general population at that age.
The comparison of our data to the
BLS3 is only speculative because of
major méthodologie differences. Nev¬
ertheless, it implies that patients with
idiopathic PD are at greater risk for
dementia than is the general popula¬
tion regardless of when the motor
manifestations begin.
In this study we found demented pa-
tients with PD to be older than nonde¬
mented patients and to have a more
rapid progression of illness and great¬
er disability, as others have found.1113
Although duration of PD is similar in
demented and nondemented patients,
the onset of dementia may reduce
survival. Mindham et al14 reported
that four of 16 demented patients died
within three years, compared with two
of the 24 nondemented patients.
Estimates of the prevalence of
intellectual decline, including demen¬
tia, in PD vary considerably.1 Brown
and Marsden2 consider this variation
to be due to differences in methods,
such as the use of nonstandardized
criteria for dementia and PD. Three
separate studies of dementia in PD1113
used similar mental status assess¬
ments. Adjusting the prevalence rates
to satisfy DSM-III criteria for demen¬
tia indicates that about 15% of the
almost 1000 patients in these three
studies were demented. This still sug¬
gests that the prevalence of dementia
is greater than in control subjects,
and Lees9 and Taylor et al10 support
this amended prevalence data. In one
Northampton region of the United
Kingdom, the prevalence of idiopathic
PD was 108.4 per 100000, and 11% of
the 223 patients with idiopathic PD
were demented by a reasonable
assessment of mental function and
disability although there were no con¬
trol subjects.15 However, in our study
we found the age-specific rates of
dementia in PD to increase signifi¬
cantly after the age of 70 years, as did
Maritila and Rinne.13
Rajput et al5 found that the proba¬
bility of developing dementia was
greater in patients with idiopathic PD
than in a comparison group of simi¬
larly aged adults. The cumulative
probability of dementia was 21.1% for
patients with PD compared with 5.7%
for control subjects after five years.
Because there is a remarkable over¬
lap in the clinical,1617 biochemical,18
and pathological19'21 manifestations of
dementia in PD and in Alzheimer's
disease, the cause of dementia in PD is
of interest. Idiopathic PD may predis¬
pose to dementia. However, the only
known risk factor is a late age at
disease onset. In addition, some types
of intellectual impairment in PD do
not warrant a diagnosis of demen¬
tia,22'25 and postmortem studies are
often inconclusive.
Using DSM-IIP criteria, it is appar¬
ent that most patients with idiopathic
PD are not demented. Our data must
be interpreted with caution because
we may have identified only severe
dementia, they were collected retro¬
spectively, and we used an external
comparison group. Nevertheless, our
results suggest that while the preva¬
lence of dementia is relatively low, the
odds of becoming demented with idio¬
pathic PD, compared with a standard
population, may be significantly
increased.
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